In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Diabetes is a condition that arises when proper blood sugar control has become defective. This leads to abnormally high blood sugar levels.

Patients with diabetes mellitus have a high risk of ... of different antihypertensive drugs must be initiated. In combination treatment, a blocker of the renin–angiotensin system should be ...

For those antidiabetic drugs that are metabolized via the CYP450 ... the manufacturer recommends that a repaglinide-metformin combination tablet should be avoided in patients with hepatic impairment.

While expected and seen as largely incremental, Jefferies analyst Peter Welford in a Tuesday note to investors said the detailed data for three early-stage assets support moving them into Phase IIb ...

In its presentation at ObesityWeek 2024 meeting in Texas, the multinational drug company AstraZeneca (NASDAQ:AZN) revealed ...

The combination of increased eating and weight loss particularly ... definitive answers about whether diabetes requires ...

Combination drugs – Combination therapies put multiple ... Please note that this page is not a comprehensive list of all available diabetes drugs.

Drugs for diabetic kidney disease treatment have greatly expanded, allowing research and consensus on their optimal use.

The AYUSH ministry aims to combine traditional and modern medicine in order to make treatments more effective and improve patient outcomes ...

Only 13 states currently offer Medicaid coverage for GLP-1 drugs, but the number of prescriptions and overall spending has ...

Radella Pharmaceuticals has reported topline outcomes from a Phase Ia trial that assessed an investigational therapy for ...